Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...

New evidence suggests that factors other than the percentage of weight loss should be considered when determining the success ...

Report’ concludes that the whole class of PFAS, except fluoropolymers, is harmful to human health and the environment.

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

While most guidelines require 6 months of behavioral interventions before prescribing weight-loss drugs, new research shows ...

Another long-term casualty of the state/local funding cuts will likely be recruiting, training, and retaining the expert ...

A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

Dr Kathleen Moore emphasizes the need for a more nuanced approach to endometrial cancer treatment, particularly in the ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 ...